Yasir Al-Wakeel, BM, BCh
2022
In 2022, Yasir Al-Wakeel, BM, BCh earned a total compensation of $1.7M as Chief Financial Officer and Head of Corporate Development at Kronos Bio, a 120% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $127,500 |
|---|---|
| Option Awards | $520,112 |
| Salary | $425,000 |
| Stock Awards | $648,560 |
| Other | $12,200 |
| Total | $1,733,372 |
BCh received $648.6K in stock awards, accounting for 37% of the total pay in 2022.
BCh also received $127.5K in non-equity incentive plan, $520.1K in option awards, $425K in salary and $12.2K in other compensation.
Rankings
In 2022, Yasir Al-Wakeel, BM, BCh's compensation ranked 1,985th out of 5,760 executives tracked by ExecPay. In other words, BCh earned more than 65.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,985 out of 5,760 | 66th |
Division Manufacturing | 1,057 out of 3,136 | 66th |
Major group Chemicals And Allied Products | 451 out of 1,422 | 68th |
Industry group Drugs | 413 out of 1,323 | 69th |
Industry Pharmaceutical Preparations | 300 out of 969 | 69th |
Source: SEC filing on April 27, 2023.
BCh's colleagues
We found two more compensation records of executives who worked with Yasir Al-Wakeel, BM, BCh at Kronos Bio in 2022.